RECRUITING

Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to address surgical health equity in historically marginalized participants with primary hyperparathyroidism (PHPT). The main questions that this study aims to answer are, how does patient navigation impact: * The proportion of PHPT participants undergo parathyroidectomy? * The proportion of PHPT participants who complete surgical consultation? * Time to surgical consultation? * Time to surgery?

Official Title

Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism

Quick Facts

Study Start:2025-01-01
Study Completion:2025-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06562881

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosed with PHPT and not yet had parathyroidectomy who meet criteria for surgical treatment of PHPT (osteoporosis, fragility fracture, or evidence of vertebral compression fracture on spine imaging, renal involvement \[renal stone, silent nephrolithiasis on renal imaging, nephrocalcinosis, hypercalciuria (24-hour urine calcium level 400 mg/dL) with increased stone risk, or impaired renal function (glomerular filtration rate 60 mL/min)\], calcium 1 mg/dL above upper limit of normal, age less than 50)
  2. * Qualify as a member of a racial or ethnic minority group (Black, Hispanic, Asian and Pacific Islander, Native American), lower socioeconomic neighborhoods (by zipcode), socially vulnerable (social determinants of health indicating financial strain, social vulnerability index in the top quartile 75%+ by zip code), or with underinsurance (Medicaid, Medicare, dual eligible, uninsured)
  1. * Prior Parathyroidectomy
  2. * End-stage Renal Disease
  3. * Renal Transplant
  4. * Vitamin D Deficiency
  5. * Metastatic Disease
  6. * Familial Hypocalciuric Hypercalcemia
  7. * No Indication for Surgery
  8. * Unable/Unwilling to provide consent

Contacts and Locations

Study Contact

Jasmine Hwang, MD
CONTACT
(267) 251-2835
Jasmine.Hwang@pennmedicine.upenn.edu
Rachel Kelz, MD
CONTACT
(215) 662-2030
Rachel.Kelz@pennmedicine.upenn.edu

Principal Investigator

Rachel Kelz, MD
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

  • Rachel Kelz, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-01
Study Completion Date2025-12-01

Study Record Updates

Study Start Date2025-01-01
Study Completion Date2025-12-01

Terms related to this study

Keywords Provided by Researchers

  • Parathyroidectomy
  • Barriers and Challenges to Surgical Health Equity

Additional Relevant MeSH Terms

  • Hyperparathyroidism, Primary